Phh (PHH) Shareholder Silver Point Capital LP Cut Its Holding by $26.52 Million; Caxton Stake In Agile Therapeutics (AGRX) Was Has Raised

January 18, 2018 - By Louis Casey

Caxton Corp increased its stake in Agile Therapeutics Inc (AGRX) by 12.1% based on its latest 2017Q3 regulatory filing with the SEC. Caxton Corp bought 196,445 shares as the company’s stock rose 35.89% with the market. The institutional investor held 1.82M shares of the health care company at the end of 2017Q3, valued at $8.12 million, up from 1.62 million at the end of the previous reported quarter. Caxton Corp who had been investing in Agile Therapeutics Inc for a number of months, seems to be bullish on the $113.50 million market cap company. The stock decreased 4.87% or $0.17 during the last trading session, reaching $3.32. About 558,806 shares traded or 8.27% up from the average. Agile Therapeutics, Inc. (NASDAQ:AGRX) has declined 48.71% since January 18, 2017 and is downtrending. It has underperformed by 65.41% the S&P500.

Edward A. Mule decreased its stake in Phh Corp (PHH) by 45.62% based on its latest 2017Q3 regulatory filing with the SEC. Silver Point Capital Lp sold 2.04 million shares as the company’s stock rose 10.02% with the market. The hedge fund run by Edward A. Mule held 2.43M shares of the diversified financial services company at the end of 2017Q3, valued at $33.87 million, down from 4.47 million at the end of the previous reported quarter. Silver Point Capital Lp who had been investing in Phh Corp for a number of months, seems to be less bullish one the $334.91 million market cap company. The stock increased 0.78% or $0.08 during the last trading session, reaching $10.29. About 213,030 shares traded. PHH Corporation (NYSE:PHH) has risen 6.41% since January 18, 2017 and is uptrending. It has underperformed by 10.29% the S&P500.

Investors sentiment increased to 1.35 in 2017 Q3. Its up 0.74, from 0.61 in 2017Q2. It improved, as 9 investors sold AGRX shares while 8 reduced holdings. 11 funds opened positions while 12 raised stakes. 23.16 million shares or 7.44% more from 21.56 million shares in 2017Q2 were reported. Moreover, Deutsche Financial Bank Ag has 0% invested in Agile Therapeutics, Inc. (NASDAQ:AGRX) for 18,236 shares. 1.22M were reported by Deerfield Mngmt Company. Morgan Stanley holds 87,124 shares or 0% of its portfolio. Investor Ab stated it has 3.51M shares or 1.01% of all its holdings. Commonwealth Of Pennsylvania Pub School Empls Retrmt System holds 0% or 30,769 shares in its portfolio. The New York-based Aisling Cap Limited Com has invested 1.32% in Agile Therapeutics, Inc. (NASDAQ:AGRX). 35,500 are owned by Janney Montgomery Scott Limited Liability Corp. Blackrock reported 108,891 shares. Element Cap Mgmt Llc has invested 0.02% in Agile Therapeutics, Inc. (NASDAQ:AGRX). Dimensional Fund LP holds 0% of its portfolio in Agile Therapeutics, Inc. (NASDAQ:AGRX) for 95,820 shares. Geode Capital Management Limited Liability Corporation has invested 0% in Agile Therapeutics, Inc. (NASDAQ:AGRX). Meeder Asset Management stated it has 0% of its portfolio in Agile Therapeutics, Inc. (NASDAQ:AGRX). Virtu Ltd Liability Company accumulated 83,806 shares. Illinois-based Alyeska Gru LP has invested 0.03% in Agile Therapeutics, Inc. (NASDAQ:AGRX). Franklin Resources holds 2.77 million shares.

Among 6 analysts covering Agile Therapeutics (NASDAQ:AGRX), 4 have Buy rating, 0 Sell and 2 Hold. Therefore 67% are positive. Agile Therapeutics had 21 analyst reports since December 30, 2015 according to SRatingsIntel. Noble Financial maintained the stock with “Buy” rating in Monday, June 12 report. The rating was initiated by Noble Financial on Wednesday, December 30 with “Buy”. The rating was maintained by Cantor Fitzgerald on Monday, November 20 with “Buy”. The rating was maintained by Noble Financial with “Buy” on Thursday, November 9. William Blair downgraded the stock to “Hold” rating in Tuesday, December 26 report. Cantor Fitzgerald maintained the stock with “Buy” rating in Monday, November 6 report. Noble Financial maintained Agile Therapeutics, Inc. (NASDAQ:AGRX) on Tuesday, June 27 with “Buy” rating. The stock of Agile Therapeutics, Inc. (NASDAQ:AGRX) earned “Buy” rating by Cantor Fitzgerald on Tuesday, October 10. As per Monday, October 2, the company rating was reinitiated by H.C. Wainwright. The rating was maintained by Cantor Fitzgerald with “Buy” on Friday, December 22.

Analysts await PHH Corporation (NYSE:PHH) to report earnings on February, 21. They expect $-1.68 EPS, up 9.68% or $0.18 from last year’s $-1.86 per share. After $-1.10 actual EPS reported by PHH Corporation for the previous quarter, Wall Street now forecasts 52.73% negative EPS growth.

Investors sentiment decreased to 0.92 in Q3 2017. Its down 0.18, from 1.1 in 2017Q2. It fall, as 21 investors sold PHH shares while 28 reduced holdings. 18 funds opened positions while 27 raised stakes. 30.18 million shares or 39.49% less from 49.87 million shares in 2017Q2 were reported. Barrow Hanley Mewhinney & Strauss Limited owns 177,130 shares. 17,333 are owned by Price T Rowe Associates Inc Md. State Board Of Administration Of Florida Retirement Sys owns 53,827 shares. Parametric Portfolio Associates Limited Liability Corp stated it has 0% of its portfolio in PHH Corporation (NYSE:PHH). Millennium Management Ltd Liability Co holds 132,276 shares or 0% of its portfolio. Bogle Inv Lp De holds 0.02% or 17,801 shares. The New York-based Engineers Gate Manager LP has invested 0.06% in PHH Corporation (NYSE:PHH). Dimensional Fund Advsr LP stated it has 3.92 million shares. Vnbtrust National Association has 0.06% invested in PHH Corporation (NYSE:PHH). Schwerin Boyle Cap stated it has 44,825 shares. The New York-based Jefferies Gp Ltd Liability Corporation has invested 0% in PHH Corporation (NYSE:PHH). Manufacturers Life Insur The reported 41,837 shares. Meridian Invest Counsel Inc stated it has 11,880 shares or 0.1% of all its holdings. Loring Wolcott Coolidge Fiduciary Ltd Liability Partnership Ma invested in 325 shares or 0% of the stock. Moreover, Geode Management Limited Liability Com has 0% invested in PHH Corporation (NYSE:PHH).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.